表紙
市場調查報告書
商品編碼
1079558

全球流感診斷測試市場:按測試類型(傳統,分子診斷檢測),用途市場規模,未來潛力,價格趨勢,COVID-19分析,競爭市場份額,未來預測2022-2028

Influenza Diagnostic Tests Market Size By Test Type (Traditional Diagnostic Test, Molecular Diagnostic Assay ), By End-use, Application Potential, Price Trends, Covid-19 Impact Analysis, Competitive Market Share & Forecast, 2022 - 2028

出版日期: | 出版商: Global Market Insights Inc. | 英文 120 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球流感診斷市場預計將從 2022 年到 2028 年顯著增長。

背景中有近期流感大流行等因素。

按測試類型,分子診斷分析預計將達到超過 6.68 億美元的規模,並在預測期內以 8.5% 的複合年增長率增長。從最終用途來看,醫院行業的市場規模預計將在 2021 年達到 5.65 億美元,並在未來幾年以前所未有的速度增長。

本報告對全球流感診斷檢測市場進行分析,從行業基本結構和向心力、技術/監管環境、主要市場推動/制約因素、檢測類型/最終用途/地區等方面進行分析。主要公司的市場趨勢展望、概況、經營業績、戰略等。

目錄

第一章分析方法/範圍

第2章執行摘要

第三章流感診斷檢測行業的思考

  • 行業分類
  • 產業情況(單位:100萬美元,2017-2028)
  • 行業影響因素
    • 生長促進劑
    • 行業潛在風險和挑戰
  • 增長潛力分析
    • 按檢查類型
    • 最終使用
  • 新型冠狀病毒感染(COVID-19)的影響分析
  • 波特分析
  • 競爭形勢 (2021)
    • 公司矩陣分析 (2021)
  • PESTEL 分析

第 4 章流感診斷檢測市場:按檢測類型

  • 主要細分市場的趨勢
  • 常規診斷測試
    • 按地區劃分的市場規模:按地區劃分(單位:100 萬美元,2016-2027 年)
    • RIDT(流感快速診斷測試)
    • DFAT(直接熒光抗體檢測)
    • 病毒培養
    • 血清學檢測
  • 分子診斷檢測
    • 逆轉錄聚合□鏈反應
    • LAMP(環介導等溫擴增法)
    • NASBAT(基於核酸序列的擴增測試)
    • SAMBA(基於簡單擴增的檢測)
    • 其他

第 5 章流感診斷檢測市場:按最終用途分類

  • 主要細分市場的趨勢
  • 醫院
  • 診斷中心
  • 研究
  • 其他

第 6 章流感診斷檢測市場:按地區劃分

  • 該地區的主要趨勢
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 意大利
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國

第 7 章公司簡介

  • 競爭儀表板 (2021)
  • F. Hoffmann-La Roche Ltd
  • Abbott
  • Becton, Dickinson and Company
  • Coris BioConcept
  • DiaSorin SpA
  • Meridian Bioscience Inc.
  • Quidel Corporation
  • Sekisui Diagnostics
  • Thermo Fischer Scientific Inc.
  • Hologic Inc.
目錄
Product Code: 4242

The market for influenza diagnostic tests would accrue massive proceeds over the span of 2022-2028. This can be backed by the growing prevalence of the influenza flu over the recent years. According to the Connecticut State Department of Public Health, a total of 265 influenza-associated hospitalizations were reported since the beginning of 2021-2022 season.

In addition, the World Health Organization claims that the annual influenza epidemics during winter and autumn affect nearly 5 to 15% of the population in the Northern hemisphere. Increase in such cases would foster the need for the development of diagnostic tests for influenza.

The overall influenza diagnostic tests market has been classified on the basis of end-use, test type, and regional landscape.

Considering the test type, the market is segmented into traditional diagnostic test and molecular diagnostic assay.

Out of these two, the industry would observe substantial growth from the molecular diagnostic assay segment, which was valued at more than $668 million. Going further, industry analysts expect the segment to expand at a CAGR of 8.5% through the analysis timeline. This can be credited to the test's capability to deliver effective and accurate testing, which is in line with its ability to offer improved efficacy, resulting in enhanced outcomes.

From the end-use standpoint, the hospitals segment has been observing a stellar growth in the global influenza diagnostic tests market. The sector was valued at $565 million in 2021, with projections expecting it to grow at an unprecedented pace in the coming years. The growth would come from positive factors such as high success rate, availability of board-certified professional doctors, and faster and high effective work, amongst others.

Geographically, Latin America influenza diagnostic tests market has been gaining significant momentum over the recent years. In 2021, the regional market share was over $173 million, and is now predicted to grow at a CAGR of 8.3% over the stipulated time frame.

The regional industry development is supported by the growing pervasiveness of influenza and surging cognizance regarding the flu infection cases in the economies like Mexico, and Brazil, among others. A recent study displayed that seasonal influenza was associated with nearly 36,500 respiratory deaths and about 400,000 hospitalizations in Latin America and the Caribbean.

Abbott, Thermo Fischer Scientific Inc., Quidel Corporation, F. Hoffmann-La Roche Ltd., Meridian Bioscience Inc., DiaSorin SpA, and Dickinson and Company are some of the prominent companies operating in the global influenza diagnostic tests market.

These companies have been working upfront to introduce new products in the space. To illustrate, in 2021, Becton, Dickinson and Company announced receiving an Emergency Use Authorization for an advanced molecular diagnostic test for Influenza A+B and SARS-CoV-2. The tests can offer results in 2-3 hours and have been CE marked to the IVD Directive.

Table of Contents

Chapter 1 Methodology

  • 1.1 Market definition
  • 1.2 Base estimates & working
  • 1.3 Forecast parameters
  • 1.4 Data validation
  • 1.5 Data sources
    • 1.5.1 Secondary
      • 1.5.1.1 Paid sources
      • 1.5.1.2 Unpaid sources
    • 1.5.2 Primary

Chapter 2 Executive Summary

  • 2.1 Influenza diagnostic tests industry 360 degree synopsis, 2017 - 2028
    • 2.1.1 Business trends
    • 2.1.2 Test type trends
    • 2.1.3 End-use trends
    • 2.1.4 Regional trends

Chapter 3 Influenza Diagnostic Tests Industry Insights

  • 3.1 Industry segmentation
  • 3.2 Industry landscape, 2017 - 2028 (USD Million)
  • 3.3 Industry impact factors
    • 3.3.1 Growth drivers
      • 3.3.1.1 Growing prevalence of influenza
      • 3.3.1.2 Rise in demand for rapid diagnostic tests
      • 3.3.1.3 Technological advancements
      • 3.3.1.4 Increase in R&D activities
    • 3.3.2 Industry pitfalls & challenges
      • 3.3.2.1 Variabilities in test sensitivity and specificity
      • 3.3.2.2 Stringent regulatory guidelines
  • 3.4 Growth potential analysis
    • 3.4.1 By test type
    • 3.4.2 By end-use
  • 3.5 COVID-19 impact analysis
  • 3.6 Porter's analysis
  • 3.7 Competitive landscape, 2021
    • 3.7.1 Company matrix analysis, 2021
  • 3.8 PESTEL analysis

Chapter 4 Influenza Diagnostic Tests Market, By Test Type

  • 4.1 Key segment trends
  • 4.2 Traditional diagnostic test
    • 4.2.1 Market size, by region, 2016 - 2027 (USD Million)
    • 4.2.2 Rapid influenza diagnostic test (RIDT)
      • 4.2.2.1 Market size, by region, 2016 - 2027 (USD Million)
    • 4.2.3 Direct fluorescent antibody test (DFAT)
      • 4.2.3.1 Market size, by region, 2016 - 2027 (USD Million)
    • 4.2.4 Viral culture
      • 4.2.4.1 Market size, by region, 2016 - 2027 (USD Million)
    • 4.2.5 Serological assay
      • 4.2.5.1 Market size, by region, 2016 - 2027 (USD Million)
  • 4.3 Molecular diagnostic assay
    • 4.3.1 Market size, by region, 2016 - 2027 (USD Million)
    • 4.3.2 RT-PCR
      • 4.3.2.1 Market size, by region, 2016 - 2027 (USD Million)
    • 4.3.3 Loop-mediated isothermal amplification-based Assay (LAMP)
      • 4.3.3.1 Market size, by region, 2016 - 2027 (USD Million)
    • 4.3.4 Nucleic acid sequence-based amplification test (NASBAT)
      • 4.3.4.1 Market size, by region, 2016 - 2027 (USD Million)
    • 4.3.5 Simple amplification-based assay (SAMBA)
      • 4.3.5.1 Market size, by region, 2016 - 2027 (USD Million)
    • 4.3.6 Others
      • 4.3.6.1 Market size, by region, 2016 - 2027 (USD Million)

Chapter 5 Influenza Diagnostic Tests Market, By End-use

  • 5.1 Key segment trends
  • 5.2 Hospitals
    • 5.2.1 Market size, by region, 2016 - 2027 (USD Million)
  • 5.3 Diagnostics centers
    • 5.3.1 Market size, by region, 2016 - 2027 (USD Million)
  • 5.4 Research laboratories
    • 5.4.1 Market size, by region, 2017 - 2028 (USD Million)
  • 5.5 Others
    • 5.5.1 Market size, by region, 2017 - 2028 (USD Million)

Chapter 6 Influenza Diagnostic Tests Market, By Region

  • 6.1 Key regional trends
  • 6.2 North America
    • 6.2.1 Market size, by country, 2017 - 2028 (USD Million)
    • 6.2.2 Market size, by test type, 2017 - 2028 (USD Million)
      • 6.2.2.1 Market size, by traditional diagnostic test, 2017 - 2028 (USD Million)
      • 6.2.2.2 Market size, by molecular diagnostic assay, 2017 - 2028 (USD Million)
    • 6.2.3 Market size, by end-use, 2016 - 2027 (USD Million)
    • 6.2.4 U.S.
      • 6.2.4.1 Market size, by test type, 2017 - 2028 (USD Million)
        • 6.2.4.1.1 Market size, by traditional diagnostic test, 2017 - 2028 (USD Million)
        • 6.2.4.1.2 Market size, by molecular diagnostic assay, 2017 - 2028 (USD Million)
      • 6.2.4.2 Market size, by end-use, 2016 - 2027 (USD Million)
    • 6.2.5 Canada
      • 6.2.5.1 Market size, by test type, 2017 - 2028 (USD Million)
        • 6.2.5.1.1 Market size, by traditional diagnostic test, 2017 - 2028 (USD Million)
        • 6.2.5.1.2 Market size, by molecular diagnostic assay, 2017 - 2028 (USD Million)
      • 6.2.5.2 Market size, by end-use, 2016 - 2027 (USD Million)
  • 6.3 Europe
    • 6.3.1 Market size, by country, 2017 - 2028 (USD Million)
    • 6.3.2 Market size, by test type, 2017 - 2028 (USD Million)
      • 6.3.2.1 Market size, by traditional diagnostic test, 2017 - 2028 (USD Million)
      • 6.3.2.2 Market size, by molecular diagnostic assay, 2017 - 2028 (USD Million)
    • 6.3.3 Market size, by end-use, 2016 - 2027 (USD Million)
    • 6.3.4 Germany
      • 6.3.4.1 Market size, by test type, 2017 - 2028 (USD Million)
        • 6.3.4.1.1 Market size, by traditional diagnostic test, 2017 - 2028 (USD Million)
        • 6.3.4.1.2 Market size, by molecular diagnostic assay, 2017 - 2028 (USD Million)
      • 6.3.4.2 Market size, by end-use, 2016 - 2027 (USD Million)
    • 6.3.5 UK
      • 6.3.5.1 Market size, by test type, 2017 - 2028 (USD Million)
        • 6.3.5.1.1 Market size, by traditional diagnostic test, 2017 - 2028 (USD Million)
        • 6.3.5.1.2 Market size, by molecular diagnostic assay, 2017 - 2028 (USD Million)
      • 6.3.5.2 Market size, by end-use, 2016 - 2027 (USD Million)
    • 6.3.6 France
      • 6.3.6.1 Market size, by test type, 2017 - 2028 (USD Million)
        • 6.3.6.1.1 Market size, by traditional diagnostic test, 2017 - 2028 (USD Million)
        • 6.3.6.1.2 Market size, by molecular diagnostic assay, 2017 - 2028 (USD Million)
      • 6.3.6.2 Market size, by end-use, 2016 - 2027 (USD Million)
    • 6.3.7 Spain
      • 6.3.7.1 Market size, by test type, 2017 - 2028 (USD Million)
        • 6.3.7.1.1 Market size, by traditional diagnostic test, 2017 - 2028 (USD Million)
        • 6.3.7.1.2 Market size, by molecular diagnostic assay, 2017 - 2028 (USD Million)
      • 6.3.7.2 Market size, by end-use, 2016 - 2027 (USD Million)
    • 6.3.8 Italy
      • 6.3.8.1 Market size, by test type, 2017 - 2028 (USD Million)
        • 6.3.8.1.1 Market size, by traditional diagnostic test, 2017 - 2028 (USD Million)
        • 6.3.8.1.2 Market size, by molecular diagnostic assay, 2017 - 2028 (USD Million)
      • 6.3.8.2 Market size, by end-use, 2016 - 2027 (USD Million)
  • 6.4 Asia Pacific
    • 6.4.1 Market size, by country, 2017 - 2028 (USD Million)
    • 6.4.2 Market size, by test type, 2017 - 2028 (USD Million)
      • 6.4.2.1 Market size, by traditional diagnostic test, 2017 - 2028 (USD Million)
      • 6.4.2.2 Market size, by molecular diagnostic assay, 2017 - 2028 (USD Million)
    • 6.4.3 Market size, by end-use, 2016 - 2027 (USD Million)
    • 6.4.4 China
      • 6.4.4.1 Market size, by test type, 2017 - 2028 (USD Million)
        • 6.4.4.1.1 Market size, by traditional diagnostic test, 2017 - 2028 (USD Million)
        • 6.4.4.1.2 Market size, by molecular diagnostic assay, 2017 - 2028 (USD Million)
      • 6.4.4.2 Market size, by end-use, 2016 - 2027 (USD Million)
    • 6.4.5 Japan
      • 6.4.5.1 Market size, by test type, 2017 - 2028 (USD Million)
        • 6.4.5.1.1 Market size, by traditional diagnostic test, 2017 - 2028 (USD Million)
        • 6.4.5.1.2 Market size, by molecular diagnostic assay, 2017 - 2028 (USD Million)
      • 6.4.5.2 Market size, by end-use, 2016 - 2027 (USD Million)
    • 6.4.6 India
      • 6.4.6.1 Market size, by test type, 2017 - 2028 (USD Million)
        • 6.4.6.1.1 Market size, by traditional diagnostic test, 2017 - 2028 (USD Million)
        • 6.4.6.1.2 Market size, by molecular diagnostic assay, 2017 - 2028 (USD Million)
      • 6.4.6.2 Market size, by end-use, 2016 - 2027 (USD Million)
    • 6.4.7 Australia
      • 6.4.7.1 Market size, by test type, 2017 - 2028 (USD Million)
        • 6.4.7.1.1 Market size, by traditional diagnostic test, 2017 - 2028 (USD Million)
        • 6.4.7.1.2 Market size, by molecular diagnostic assay, 2017 - 2028 (USD Million)
      • 6.4.7.2 Market size, by end-use, 2016 - 2027 (USD Million)
    • 6.4.8 South Korea
      • 6.4.8.1 Market size, by test type, 2017 - 2028 (USD Million)
        • 6.4.8.1.1 Market size, by traditional diagnostic test, 2017 - 2028 (USD Million)
        • 6.4.8.1.2 Market size, by molecular diagnostic assay, 2017 - 2028 (USD Million)
      • 6.4.8.2 Market size, by end-use, 2016 - 2027 (USD Million)
  • 6.5 Latin America
    • 6.5.1 Market size, by country, 2017 - 2028 (USD Million)
    • 6.5.2 Market size, by test type, 2017 - 2028 (USD Million)
      • 6.5.2.1 Market size, by traditional diagnostic test, 2017 - 2028 (USD Million)
      • 6.5.2.2 Market size, by molecular diagnostic assay, 2017 - 2028 (USD Million)
    • 6.5.3 Market size, by end-use, 2016 - 2027 (USD Million)
    • 6.5.4 Brazil
      • 6.5.4.1 Market size, by test type, 2017 - 2028 (USD Million)
        • 6.5.4.1.1 Market size, by traditional diagnostic test, 2017 - 2028 (USD Million)
        • 6.5.4.1.2 Market size, by molecular diagnostic assay, 2017 - 2028 (USD Million)
      • 6.5.4.2 Market size, by end-use, 2016 - 2027 (USD Million)
    • 6.5.5 Mexico
      • 6.5.5.1 Market size, by test type, 2017 - 2028 (USD Million)
        • 6.5.5.1.1 Market size, by traditional diagnostic test, 2017 - 2028 (USD Million)
        • 6.5.5.1.2 Market size, by molecular diagnostic assay, 2017 - 2028 (USD Million)
      • 6.5.5.2 Market size, by end-use, 2016 - 2027 (USD Million)
    • 6.5.6 Argentina
      • 6.5.6.1 Market size, by test type, 2017 - 2028 (USD Million)
        • 6.5.6.1.1 Market size, by traditional diagnostic test, 2017 - 2028 (USD Million)
        • 6.5.6.1.2 Market size, by molecular diagnostic assay, 2017 - 2028 (USD Million)
      • 6.5.6.2 Market size, by end-use, 2016 - 2027 (USD Million)
  • 6.6 Middle East and Africa
    • 6.6.1 Market size, by country, 2017 - 2028 (USD Million)
    • 6.6.2 Market size, by test type, 2017 - 2028 (USD Million)
      • 6.6.2.1 Market size, by traditional diagnostic test, 2017 - 2028 (USD Million)
      • 6.6.2.2 Market size, by molecular diagnostic assay, 2017 - 2028 (USD Million)
    • 6.6.3 Market size, by end-use, 2016 - 2027 (USD Million)
    • 6.6.4 South Africa
      • 6.6.4.1 Market size, by test type, 2017 - 2028 (USD Million)
        • 6.6.4.1.1 Market size, by traditional diagnostic test, 2017 - 2028 (USD Million)
        • 6.6.4.1.2 Market size, by molecular diagnostic assay, 2017 - 2028 (USD Million)
      • 6.6.4.2 Market size, by end-use, 2016 - 2027 (USD Million)
    • 6.6.5 Saudi Arabia
      • 6.6.5.1 Market size, by test type, 2017 - 2028 (USD Million)
        • 6.6.5.1.1 Market size, by traditional diagnostic test, 2017 - 2028 (USD Million)
        • 6.6.5.1.2 Market size, by molecular diagnostic assay, 2017 - 2028 (USD Million)
      • 6.6.5.2 Market size, by end-use, 2016 - 2027 (USD Million)
    • 6.6.6 UAE
      • 6.6.6.1 Market size, by test type, 2017 - 2028 (USD Million)
        • 6.6.6.1.1 Market size, by traditional diagnostic test, 2017 - 2028 (USD Million)
        • 6.6.6.1.2 Market size, by molecular diagnostic assay, 2017 - 2028 (USD Million)
      • 6.6.6.2 Market size, by end-use, 2016 - 2027 (USD Million)

Chapter 7 Company Profiles

  • 7.1 Competitive dashboard, 2021
  • 7.2 F. Hoffmann-La Roche Ltd
    • 7.2.1 Business overview
    • 7.2.2 Financial data
    • 7.2.3 Product landscape
    • 7.2.4 Strategic outlook
    • 7.2.5 SWOT analysis
  • 7.3 Abbott
    • 7.3.1 Business overview
    • 7.3.2 Financial data
    • 7.3.3 Product landscape
    • 7.3.4 Strategic outlook
    • 7.3.5 SWOT analysis
  • 7.4 Becton, Dickinson and Company
    • 7.4.1 Business overview
    • 7.4.2 Financial data
    • 7.4.3 Product landscape
    • 7.4.4 Strategic outlook
    • 7.4.5 SWOT analysis
  • 7.5 Coris BioConcept
    • 7.5.1 Business overview
    • 7.5.2 Financial data
    • 7.5.3 Product landscape
    • 7.5.4 Strategic outlook
    • 7.5.5 SWOT analysis
  • 7.6 DiaSorin SpA
    • 7.6.1 Business overview
    • 7.6.2 Financial data
    • 7.6.3 Product landscape
    • 7.6.4 Strategic outlook
    • 7.6.5 SWOT analysis
  • 7.7 Meridian Bioscience Inc.
    • 7.7.1 Business overview
    • 7.7.2 Financial data
    • 7.7.3 Product landscape
    • 7.7.4 Strategic outlook
    • 7.7.5 SWOT analysis
  • 7.8 Quidel Corporation
    • 7.8.1 Business overview
    • 7.8.2 Financial data
    • 7.8.3 Product landscape
    • 7.8.4 Strategic outlook
    • 7.8.5 SWOT analysis
  • 7.9 Sekisui Diagnostics
    • 7.9.1 Business overview
    • 7.9.2 Financial data
    • 7.9.3 Product landscape
    • 7.9.4 Strategic outlook
    • 7.9.5 SWOT analysis
  • 7.10 Thermo Fischer Scientific Inc.
    • 7.10.1 Business overview
    • 7.10.2 Financial data
    • 7.10.3 Product landscape
    • 7.10.4 Strategic outlook
    • 7.10.5 SWOT analysis
  • 7.11 Hologic Inc.
    • 7.11.1 Business overview
    • 7.11.2 Financial data
    • 7.11.3 Product landscape
    • 7.11.4 Strategic outlook
    • 7.11.5 SWOT analysis

Data Tables

  • TABLE 1. Global influenza diagnostic tests market, 2017 - 2021 (USD Million)
  • TABLE 2. Global influenza diagnostic tests market, 2022 - 2028 (USD Million)
  • TABLE 3. Global influenza diagnostic tests market, by test type, 2017 - 2021 (USD Million)
  • TABLE 4. Global influenza diagnostic tests market, by test type, 2022 - 2028 (USD Million)
  • TABLE 5. Global influenza diagnostic tests market, by end-use, 2017 - 2021 (USD Million)
  • TABLE 6. Global influenza diagnostic tests market, by end-use, 2022 - 2028 (USD Million)
  • TABLE 7. Global influenza diagnostic tests market, by region, 2017 - 2021 (USD Million)
  • TABLE 8. Global influenza diagnostic tests market, by region, 2022 - 2028 (USD Million)
  • TABLE 9. Industry impact forces
  • TABLE 10. Traditional diagnostic test market size, by region, 2017 - 2021 (USD Million)
  • TABLE 11. Traditional diagnostic test market size, by region, 2022 - 2028 (USD Million)
  • TABLE 12. Rapid influenza diagnostic test (RIDT) market size, by region, 2017 - 2021 (USD Million)
  • TABLE 13. Rapid influenza diagnostic test (RIDT) market size, by region, 2022 - 2028 (USD Million)
  • TABLE 14. Direct fluorescent antibody test (DFAT) market size, by region, 2017 - 2021 (USD Million)
  • TABLE 15. Direct fluorescent antibody test (DFAT) market size, by region, 2022 - 2028 (USD Million)
  • TABLE 16. Viral culture market size, by region, 2017 - 2021 (USD Million)
  • TABLE 17. Viral culture market size, by region, 2022 - 2028 (USD Million)
  • TABLE 18. Serological assay market size, by region, 2017 - 2021 (USD Million)
  • TABLE 19. Serological assay market size, by region, 2022 - 2028 (USD Million)
  • TABLE 20. Molecular diagnostic assay market size, by region, 2017 - 2021 (USD Million)
  • TABLE 21. Molecular diagnostic assay market size, by region, 2022 - 2028 (USD Million)
  • TABLE 22. RT-PCR market size, by region, 2017 - 2021 (USD Million)
  • TABLE 23. RT-PCR market size, by region, 2022 - 2028 (USD Million)
  • TABLE 24. Loop-mediated isothermal amplification-based assay (LAMP) market size, by region, 2017 - 2021 (USD Million)
  • TABLE 25. Loop-mediated isothermal amplification-based assay (LAMP) market size, by region, 2022 - 2028 (USD Million)
  • TABLE 26. Nucleic acid sequence-based amplification test (NASBAT) market size, by region, 2017 - 2021 (USD Million)
  • TABLE 27. Nucleic Acid sequence-based amplification test (NASBAT) market size, by region, 2022 - 2028 (USD Million)
  • TABLE 28. Simple amplification-based Assay (SAMBA) market size, by region, 2017 - 2021 (USD Million)
  • TABLE 29. Simple amplification-based Assay (SAMBA) market size, by region, 2022 - 2028 (USD Million)
  • TABLE 30. Others market size, by region, 2017 - 2021 (USD Million)
  • TABLE 31. Others market size, by region, 2022 - 2028 (USD Million)
  • TABLE 32. Hospitals market size, by region, 2017 - 2021 (USD Million)
  • TABLE 33. Hospitals market size, by region, 2022 - 2028 (USD Million)
  • TABLE 34. Diagnostics centers market size, by region, 2017 - 2021 (USD Million)
  • TABLE 35. Diagnostics centers market size, by region, 2022 - 2028 (USD Million)
  • TABLE 36. Research laboratories market size, by region, 2017 - 2021 (USD Million)
  • TABLE 37. Research laboratories market size, by region, 2022 - 2028 (USD Million)
  • TABLE 38. Others market size, by region, 2017 - 2021 (USD Million)
  • TABLE 39. Others market size, by region, 2022 - 2028 (USD Million)
  • TABLE 40. North America influenza diagnostic tests market size, by country, 2017 - 2021 (USD Million)
  • TABLE 41. North America influenza diagnostic tests market size, by country, 2022 - 2028 (USD Million)
  • TABLE 42. North America influenza diagnostic tests market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 43. North America influenza diagnostic tests market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 44. North America influenza diagnostic tests market size, by traditional diagnostic test, 2017 - 2021 (USD Million)
  • TABLE 45. North America influenza diagnostic tests market size, by traditional diagnostic test, 2022 - 2028 (USD Million)
  • TABLE 46. North America influenza diagnostic tests market size, by molecular diagnostic assay, 2017 - 2021 (USD Million)
  • TABLE 47. North America influenza diagnostic tests market size, by molecular diagnostic assay, 2022 - 2028 (USD Million)
  • TABLE 48. North America influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 49. North America influenza diagnostic tests market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 50. U.S. influenza diagnostic tests market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 51. U.S. influenza diagnostic tests market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 52. U.S. influenza diagnostic tests market size, by traditional diagnostic test, 2017 - 2021 (USD Million)
  • TABLE 53. U.S. influenza diagnostic tests market size, by traditional diagnostic test, 2022 - 2028 (USD Million)
  • TABLE 54. U.S. influenza diagnostic tests market size, by molecular diagnostic assay, 2017 - 2021 (USD Million)
  • TABLE 55. U.S. influenza diagnostic tests market size, by molecular diagnostic assay, 2022 - 2028 (USD Million)
  • TABLE 56. U.S. influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 57. U.S. influenza diagnostic tests market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 58. Canada influenza diagnostic tests market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 59. Canada influenza diagnostic tests market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 60. Canada influenza diagnostic tests market size, by traditional diagnostic test, 2017 - 2021 (USD Million)
  • TABLE 61. Canada influenza diagnostic tests market size, by traditional diagnostic test, 2022 - 2028 (USD Million)
  • TABLE 62. Canada influenza diagnostic tests market size, by molecular diagnostic assay, 2017 - 2021 (USD Million)
  • TABLE 63. Canada influenza diagnostic tests market size, by molecular diagnostic assay, 2022 - 2028 (USD Million)
  • TABLE 64. Canada influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 65. Canada influenza diagnostic tests market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 66. Europe influenza diagnostic tests market size, by country, 2017 - 2021 (USD Million)
  • TABLE 67. Europe influenza diagnostic tests market size, by country, 2022 - 2028 (USD Million)
  • TABLE 68. Europe influenza diagnostic tests market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 69. Europe influenza diagnostic tests market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 70. Europe influenza diagnostic tests market size, by traditional diagnostic test, 2017 - 2021 (USD Million)
  • TABLE 71. Europe influenza diagnostic tests market size, by traditional diagnostic test, 2022 - 2028 (USD Million)
  • TABLE 72. Europe influenza diagnostic tests market size, by molecular diagnostic assay, 2017 - 2021 (USD Million)
  • TABLE 73. Europe influenza diagnostic tests market size, by molecular diagnostic assay, 2022 - 2028 (USD Million)
  • TABLE 74. Europe influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 75. Europe influenza diagnostic tests market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 76. Germany influenza diagnostic tests market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 77. Germany influenza diagnostic tests market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 78. Germany influenza diagnostic tests market size, by traditional diagnostic test, 2017 - 2021 (USD Million)
  • TABLE 79. Germany influenza diagnostic tests market size, by traditional diagnostic test, 2022 - 2028 (USD Million)
  • TABLE 80. Germany influenza diagnostic tests market size, by molecular diagnostic assay, 2017 - 2021 (USD Million)
  • TABLE 81. Germany influenza diagnostic tests market size, by molecular diagnostic assay, 2022 - 2028 (USD Million)
  • TABLE 82. Germany influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 83. Germany influenza diagnostic tests market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 84. UK influenza diagnostic tests market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 85. UK influenza diagnostic tests market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 86. UK influenza diagnostic tests market size, by traditional diagnostic test, 2017 - 2021 (USD Million)
  • TABLE 87. UK influenza diagnostic tests market size, by traditional diagnostic test, 2022 - 2028 (USD Million)
  • TABLE 88. UK influenza diagnostic tests market size, by molecular diagnostic assay, 2017 - 2021 (USD Million)
  • TABLE 89. UK influenza diagnostic tests market size, by molecular diagnostic assay, 2022 - 2028 (USD Million)
  • TABLE 90. UK influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 91. UK influenza diagnostic tests market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 92. France influenza diagnostic tests market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 93. France influenza diagnostic tests market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 94. France influenza diagnostic tests market size, by traditional diagnostic test, 2017 - 2021 (USD Million)
  • TABLE 95. France influenza diagnostic tests market size, by traditional diagnostic test, 2022 - 2028 (USD Million)
  • TABLE 96. France influenza diagnostic tests market size, by molecular diagnostic assay, 2017 - 2021 (USD Million)
  • TABLE 97. France influenza diagnostic tests market size, by molecular diagnostic assay, 2022 - 2028 (USD Million)
  • TABLE 98. France influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 99. France influenza diagnostic tests market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 100. Spain influenza diagnostic tests market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 101. Spain influenza diagnostic tests market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 102. Spain influenza diagnostic tests market size, by traditional diagnostic test, 2017 - 2021 (USD Million)
  • TABLE 103. Spain influenza diagnostic tests market size, by traditional diagnostic test, 2022 - 2028 (USD Million)
  • TABLE 104. Spain influenza diagnostic tests market size, by molecular diagnostic assay, 2017 - 2021 (USD Million)
  • TABLE 105. Spain influenza diagnostic tests market size, by molecular diagnostic assay, 2022 - 2028 (USD Million)
  • TABLE 106. Spain influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 107. Spain influenza diagnostic tests market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 108. Italy influenza diagnostic tests market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 109. Italy influenza diagnostic tests market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 110. Italy influenza diagnostic tests market size, by traditional diagnostic test, 2017 - 2021 (USD Million)
  • TABLE 111. Italy influenza diagnostic tests market size, by traditional diagnostic test, 2022 - 2028 (USD Million)
  • TABLE 112. Italy influenza diagnostic tests market size, by molecular diagnostic assay, 2017 - 2021 (USD Million)
  • TABLE 113. Italy influenza diagnostic tests market size, by molecular diagnostic assay, 2022 - 2028 (USD Million)
  • TABLE 114. Italy influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 115. Italy influenza diagnostic tests market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 116. Asia Pacific influenza diagnostic tests market size, by country, 2017 - 2021 (USD Million)
  • TABLE 117. Asia Pacific influenza diagnostic tests market size, by country, 2022 - 2028 (USD Million)
  • TABLE 118. Asia Pacific influenza diagnostic tests market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 119. Asia Pacific influenza diagnostic tests market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 120. Asia Pacific influenza diagnostic tests market size, by traditional diagnostic test, 2017 - 2021 (USD Million)
  • TABLE 121. Asia Pacific influenza diagnostic tests market size, by traditional diagnostic test, 2022 - 2028 (USD Million)
  • TABLE 122. Asia Pacific influenza diagnostic tests market size, by molecular diagnostic assay, 2017 - 2021 (USD Million)
  • TABLE 123. Asia Pacific influenza diagnostic tests market size, by molecular diagnostic assay, 2022 - 2028 (USD Million)
  • TABLE 124. Asia Pacific influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 125. Asia Pacific influenza diagnostic tests market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 126. China influenza diagnostic tests market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 127. China influenza diagnostic tests market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 128. China influenza diagnostic tests market size, by traditional diagnostic test, 2017 - 2021 (USD Million)
  • TABLE 129. China influenza diagnostic tests market size, by traditional diagnostic test, 2022 - 2028 (USD Million)
  • TABLE 130. China influenza diagnostic tests market size, by molecular diagnostic assay, 2017 - 2021 (USD Million)
  • TABLE 131. China influenza diagnostic tests market size, by molecular diagnostic assay, 2022 - 2028 (USD Million)
  • TABLE 132. China influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 133. China influenza diagnostic tests market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 134. Japan influenza diagnostic tests market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 135. Japan influenza diagnostic tests market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 136. Japan influenza diagnostic tests market size, by traditional diagnostic test, 2017 - 2021 (USD Million)
  • TABLE 137. Japan influenza diagnostic tests market size, by traditional diagnostic test, 2022 - 2028 (USD Million)
  • TABLE 138. Japan influenza diagnostic tests market size, by molecular diagnostic assay, 2017 - 2021 (USD Million)
  • TABLE 139. Japan influenza diagnostic tests market size, by molecular diagnostic assay, 2022 - 2028 (USD Million)
  • TABLE 140. Japan influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 141. Japan influenza diagnostic tests market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 142. India influenza diagnostic tests market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 143. India influenza diagnostic tests market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 144. India influenza diagnostic tests market size, by traditional diagnostic test, 2017 - 2021 (USD Million)
  • TABLE 145. India influenza diagnostic tests market size, by traditional diagnostic test, 2022 - 2028 (USD Million)
  • TABLE 146. India influenza diagnostic tests market size, by molecular diagnostic assay, 2017 - 2021 (USD Million)
  • TABLE 147. India influenza diagnostic tests market size, by molecular diagnostic assay, 2022 - 2028 (USD Million)
  • TABLE 148. India influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 149. India influenza diagnostic tests market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 150. Australia influenza diagnostic tests market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 151. Australia influenza diagnostic tests market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 152. Australia influenza diagnostic tests market size, by traditional diagnostic test, 2017 - 2021 (USD Million)
  • TABLE 153. Australia influenza diagnostic tests market size, by traditional diagnostic test, 2022 - 2028 (USD Million)
  • TABLE 154. Australia influenza diagnostic tests market size, by molecular diagnostic assay, 2017 - 2021 (USD Million)
  • TABLE 155. Australia influenza diagnostic tests market size, by molecular diagnostic assay, 2022 - 2028 (USD Million)
  • TABLE 156. Australia influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 157. Australia influenza diagnostic tests market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 158. South Korea influenza diagnostic tests market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 159. South Korea influenza diagnostic tests market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 160. South Korea influenza diagnostic tests market size, by traditional diagnostic test, 2017 - 2021 (USD Million)
  • TABLE 161. South Korea influenza diagnostic tests market size, by traditional diagnostic test, 2022 - 2028 (USD Million)
  • TABLE 162. South Korea influenza diagnostic tests market size, by molecular diagnostic assay, 2017 - 2021 (USD Million)
  • TABLE 163. South Korea influenza diagnostic tests market size, by molecular diagnostic assay, 2022 - 2028 (USD Million)
  • TABLE 164. South Korea influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 165. South Korea influenza diagnostic tests market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 166. Latin America influenza diagnostic tests market size, by country, 2017 - 2021 (USD Million)
  • TABLE 167. Latin America influenza diagnostic tests market size, by country, 2022 - 2028 (USD Million)
  • TABLE 168. Latin America influenza diagnostic tests market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 169. Latin America influenza diagnostic tests market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 170. Latin America influenza diagnostic tests market size, by traditional diagnostic test, 2017 - 2021 (USD Million)
  • TABLE 171. Latin America influenza diagnostic tests market size, by traditional diagnostic test, 2022 - 2028 (USD Million)
  • TABLE 172. Latin America influenza diagnostic tests market size, by molecular diagnostic assay, 2017 - 2021 (USD Million)
  • TABLE 173. Latin America influenza diagnostic tests market size, by molecular diagnostic assay, 2022 - 2028 (USD Million)
  • TABLE 174. Latin America influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 175. Latin America influenza diagnostic tests market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 176. Brazil influenza diagnostic tests market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 177. Brazil influenza diagnostic tests market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 178. Brazil influenza diagnostic tests market size, by traditional diagnostic test, 2017 - 2021 (USD Million)
  • TABLE 179. Brazil influenza diagnostic tests market size, by traditional diagnostic test, 2022 - 2028 (USD Million)
  • TABLE 180. Brazil influenza diagnostic tests market size, by molecular diagnostic assay, 2017 - 2021 (USD Million)
  • TABLE 181. Brazil influenza diagnostic tests market size, by molecular diagnostic assay, 2022 - 2028 (USD Million)
  • TABLE 182. Brazil influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 183. Brazil influenza diagnostic tests market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 184. Mexico influenza diagnostic tests market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 185. Mexico influenza diagnostic tests market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 186. Mexico influenza diagnostic tests market size, by traditional diagnostic test, 2017 - 2021 (USD Million)
  • TABLE 187. Mexico influenza diagnostic tests market size, by traditional diagnostic test, 2022 - 2028 (USD Million)
  • TABLE 188. Mexico influenza diagnostic tests market size, by molecular diagnostic assay, 2017 - 2021 (USD Million)
  • TABLE 189. Mexico influenza diagnostic tests market size, by molecular diagnostic assay, 2022 - 2028 (USD Million)
  • TABLE 190. Mexico influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 191. Mexico influenza diagnostic tests market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 192. Argentina influenza diagnostic tests market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 193. Argentina influenza diagnostic tests market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 194. Argentina influenza diagnostic tests market size, by traditional diagnostic test, 2017 - 2021 (USD Million)
  • TABLE 195. Argentina influenza diagnostic tests market size, by traditional diagnostic test, 2022 - 2028 (USD Million)
  • TABLE 196. Argentina influenza diagnostic tests market size, by molecular diagnostic assay, 2017 - 2021 (USD Million)
  • TABLE 197. Argentina influenza diagnostic tests market size, by molecular diagnostic assay, 2022 - 2028 (USD Million)
  • TABLE 198. Argentina influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 199. Argentina influenza diagnostic tests market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 200. MEA influenza diagnostic tests market size, by country, 2017 - 2021 (USD Million)
  • TABLE 201. MEA influenza diagnostic tests market size, by country, 2022 - 2028 (USD Million)
  • TABLE 202. MEA influenza diagnostic tests market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 203. MEA influenza diagnostic tests market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 204. MEA influenza diagnostic tests market size, by traditional diagnostic test, 2017 - 2021 (USD Million)
  • TABLE 205. MEA influenza diagnostic tests market size, by traditional diagnostic test, 2022 - 2028 (USD Million)
  • TABLE 206. MEA influenza diagnostic tests market size, by molecular diagnostic assay, 2017 - 2021 (USD Million)
  • TABLE 207. MEA influenza diagnostic tests market size, by molecular diagnostic assay, 2022 - 2028 (USD Million)
  • TABLE 208. MEA influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 209. MEA influenza diagnostic tests market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 210. South Africa influenza diagnostic tests market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 211. South Africa influenza diagnostic tests market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 212. South Africa influenza diagnostic tests market size, by traditional diagnostic test, 2017 - 2021 (USD Million)
  • TABLE 213. South Africa influenza diagnostic tests market size, by traditional diagnostic test, 2022 - 2028 (USD Million)
  • TABLE 214. South Africa influenza diagnostic tests market size, by molecular diagnostic assay, 2017 - 2021 (USD Million)
  • TABLE 215. South Africa influenza diagnostic tests market size, by molecular diagnostic assay, 2022 - 2028 (USD Million)
  • TABLE 216. South Africa influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 217. South Africa influenza diagnostic tests market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 218. Saudi Arabia influenza diagnostic tests market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 219. Saudi Arabia influenza diagnostic tests market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 220. Saudi Arabia influenza diagnostic tests market size, by traditional diagnostic test, 2017 - 2021 (USD Million)
  • TABLE 221. Saudi Arabia influenza diagnostic tests market size, by traditional diagnostic test, 2022 - 2028 (USD Million)
  • TABLE 222. Saudi Arabia influenza diagnostic tests market size, by molecular diagnostic assay, 2017 - 2021 (USD Million)
  • TABLE 223. Saudi Arabia influenza diagnostic tests market size, by molecular diagnostic assay, 2022 - 2028 (USD Million)
  • TABLE 224. Saudi Arabia influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 225. Saudi Arabia influenza diagnostic tests market size, by end-use, 2022 - 2028 (USD Million)
  • TABLE 226. UAE influenza diagnostic tests market size, by test type, 2017 - 2021 (USD Million)
  • TABLE 227. UAE influenza diagnostic tests market size, by test type, 2022 - 2028 (USD Million)
  • TABLE 228. UAE influenza diagnostic tests market size, by traditional diagnostic test, 2017 - 2021 (USD Million)
  • TABLE 229. UAE influenza diagnostic tests market size, by traditional diagnostic test, 2022 - 2028 (USD Million)
  • TABLE 230. UAE influenza diagnostic tests market size, by molecular diagnostic assay, 2017 - 2021 (USD Million)
  • TABLE 231. UAE influenza diagnostic tests market size, by molecular diagnostic assay, 2022 - 2028 (USD Million)
  • TABLE 232. UAE influenza diagnostic tests market size, by end-use, 2017 - 2021 (USD Million)
  • TABLE 233. UAE influenza diagnostic tests market size, by end-use, 2022 - 2028 (USD Million)

Charts & Figures

  • FIG. 1 Top-down approach (Supply side analysis)
  • FIG. 2 Data Validation
  • FIG. 3 Influenza diagnostic tests market size, 2017 -2028 (USD Million)
  • FIG. 4 Industry segmentation
  • FIG. 5 Global influenza diagnostic tests market, 2017-2028 (USD Million)
  • FIG. 6 Growth potential analysis, by test type
  • FIG. 7 Growth potential analysis, by end-use
  • FIG. 8 Porter's analysis
  • FIG. 9 Company matrix analysis, 2021
  • FIG. 10 PESTEL analysis
  • FIG. 11 Key segment trends, by test type
  • FIG. 12 Key segment trends, by end-use
  • FIG. 13 Key regional trends
  • FIG. 14 Competitive dashboard, 2021